HALEOS LABS LIMITED (HALEOSLABS) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 2006, SMS Lifesciences Ltd is in the business of manufacturing of Active Pharma Ingredients and their intermediates[1]

HALEOSLABSUpdated 7 Sept 2026, 1:54

Haleos Labs Limited

Market Cap

₹439Cr.

Current Price

₹1,451

High / Low

₹1,778/1,091

Stock P/E

27.7

ROE8.64%
ROCE10.6%
Book Value₹710
Face Value₹10.0
Dividend Yield0.10%

About

Incorporated in 2006, SMS Lifesciences Ltd is in the business of manufacturing of Active Pharma Ingredients and their intermediates[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days65463931423653607166
Inventory Days133135117138154143154168131183
Days Payable1681221339114712410511199141
Cash Conversion Cycle306023784854102116102108
Working Capital Days43412027314465615757
ROCE %0%46%9%22%12%14%13%9%11%14%11%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 7 September 2026 at 1:54


Designed & Shipped by Harshit Bansal